School of Medicine
Showing 21-40 of 556 Results
-
Ehsan Rahimy
Adjunct Clinical Assistant Professor, Ophthalmology
BioDr. Ehsan Rahimy specializes in the medical and surgical management of diseases affecting the retina, with a clinical expertise in macular degeneration, diabetic retinopathy, retinal detachment, macular hole, macular pucker/epiretinal membranes, and uveitis.
Dr. Rahimy has authored well over 100 peer-reviewed publications, numerous book chapters, as well as other non-peer reviewed literature. He presents regularly at national and international ophthalmic meetings, having contributed over 200 conference abstracts.
He is passionate about the interplay between technology and medicine, and how ongoing advancements will transform healthcare delivery in the near future. Dr. Rahimy is frequently consulted for collaborative research endeavors and advises on numerous early stage companies involved in ophthalmology, telemedicine, A.I., and other medtech innovation.
Dr. Rahimy graduated with highest distinction from the University of Michigan, followed by receiving his medical degree, with high honors, at Baylor College of Medicine. During this time, he was one of a select few junior inductees into the Alpha Omega Alpha (AOA) Honor Society. He went on to complete his ophthalmology residency at the world-renowned Jules Stein Eye Institute at UCLA, recognized as one of the premier residency programs in the country, where he received the Pepose-Saltzman Young Investigator Research Award, Henry & Lilian Nesburn Research Award, and the Devgan Outstanding Surgical Resident Award. Afterwards, he pursued subspecialty training in vitreoretinal surgery at Wills Eye Hospital, considered the preeminent retinal fellowship program in the country, under the guidance and mentorship of many of the field's leaders. While there, he was awarded a Heed Fellowship, the Ronald G. Michels Fellowship Award, and the William B. Tasman Outstanding Fellow Award. -
Vasiliki Rahimzadeh
Member, Maternal & Child Health Research Institute (MCHRI)
BioVasiliki (Vaso) Rahimzadeh, PhD is an applied bioethics scholar with research interests at the intersection of precision medicine, data governance and public policy.
-
Shamma Shakila Rahman
Postdoctoral Scholar, Human Gene Therapy
Current Research and Scholarly InterestsImmunological pathophysiology of Pediatric Acute-onset Neuropsychiatric Syndrome
-
Zakia Rahman, MD
Clinical Professor, Dermatology
BioZakia Rahman, M.D., is Clinical Professor, Assistant Chief at the Livermore Division of the PAVAHCS and Director of the Resident Laser and Aesthetic Clinic. Dr. Rahman serves on the American Academy of Dermatology Diversity Committee. She also is member of the Stanford Physician Wellness Committee and the Stanford Medical School Faculty Senate. Her clinical interests include geriatric dermatology, surgical dermatology, lasers, ethnic skin, fillers and neurotoxins for medical and aesthetic indications. Her research interests include lasers for medical and aesthetic indications and ethnic skin.
-
Hannah Elizabeth Raila
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioDr. Hannah Raila's training focuses the "diet" of visual information that we consume as we navigate the world (e.g., do we see the crack in the wall, or do we pass by it unaware?), the factors that predispose us to detect this emotional information in our environment the first place, and how this diet of information influences our emotions. To study our visual biases and how they relate to how we feel, she leverages tools from cognitive psychology - including eye tracking and continuous flash suppression (CFS).
As a postdoctoral researcher in Dr. Carolyn Rodriguez's lab, she is particularly interested in links between visual attention and emotion in OCD, and whether biased visual processing of obsession-related cues contributes to symptom severity. -
Douglas Rait
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Rait's clinical and research interests include couples and family therapy, the family context of health and illness, family-systems training in medical education, work-couple-family balance, the influence of technology on family relationships, health technology innovation, multidisciplinary team performance, and digital applications in the behavioral sciences.
-
Kristin Raj
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Raj specializes in the treatment of mood disorders with an expertise in neuromodulation and in the psychopharmacological management of bipolar disorder. She is co-chief of the mood disorders section and chief of the bipolar clinic. She is the director of education for interventional psychiatry where she manages resident education in ECT and TMS and development of didactics. She is also co-director of the neuroscience curriculum for the psychiatry residency where she has worked to assess and create a new series of interactive lectures. She currently serves on the Board of Directors and the Education Committee of the Clinical TMS society. She is on the Education Committee of the National Neurosciences Curriculum Initiative.
-
Rishi Raj
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Rishi Raj is an Clinical Professor of Medicine at Stanford University and directs the Interstitial Lung Disease program at Stanford. He specializes in the diagnosis and treatment of interstitial lung diseases and has practiced pulmonary and critical care medicine for more than 15 years. Dr. Raj's primary clinical interest and primary focus of clinical research is interstitial lung diseases including idiopathic pulmonary fibrosis, other idiopathic interstitial lung diseases, drug induced interstitial lung diseases, interstitial lung disease associated with connective tissue diseases including scleroderma, rheumatoid arthritis, dermatomyositis etc., sarcoidosis, hypersensitivity pneumonitis and other miscellaneous interstitial lung diseases. Dr. Raj is the principal investigator and co-investigator on multiple clinical trials evaluating new therapies for treating idiopathic pulmonary fibrosis and pulmonary fibrosis/interstitial lung disease from other etiologies.
